These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6240596)

  • 1. Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation.
    Erdei A; Spaeth E; Alsenz J; Rüde E; Schulz T; Gergely J; Dierich MP
    Mol Immunol; 1984 Dec; 21(12):1215-21. PubMed ID: 6240596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between C3 and IL-2; inhibition of C3b binding to CR1 by IL-2.
    Bartók I; Erdei A; Mouzaki A; Osawa H; Szölösi J; Eigentler A; Diamantstein T; Dierich MP; Gergely J
    Immunol Lett; 1989 May; 21(2):131-7. PubMed ID: 2527811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 cleaved by membrane proteases binds to C3b acceptors expressed on concanavalin A-stimulated human lymphocytes and enhances antibody-dependent cellular cytotoxicity.
    Erdei A; Benczur M; Fábry Z; Dierich MP; Gergely J
    Scand J Immunol; 1984 Aug; 20(2):125-31. PubMed ID: 6236547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Fc receptor mediated functions by split products of C3.
    Gergely J; Erdei A; Fábry Z
    Mol Immunol; 1984 Dec; 21(12):1205-10. PubMed ID: 6240595
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of fluid-phase complement components C3 and C3b to human lymphocytes.
    Sim E; Sim RB
    Biochem J; 1981 Sep; 198(3):509-18. PubMed ID: 7326019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3 modified at the thiolester site: acquisition of reactivity with cellular C3b receptors.
    Schreiber RD; Pangburn MK; Müller-Eberhard HJ
    Biosci Rep; 1981 Nov; 1(11):873-80. PubMed ID: 6458338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
    Arvieux J; Yssel H; Colomb MG
    Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
    Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
    Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3b acceptors on macrophages: inhibition of Fc gamma-receptor-mediated phagocytosis by acceptor-bound C3b.
    Fábry Z; Erdei A; Gergely J
    Immunol Lett; 1983 Jun; 6(6):287-91. PubMed ID: 6226600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragments.
    Sármay G; Ramos OF; Klein E; Kai C; Gergely J
    Eur J Immunol; 1987 Jul; 17(7):969-74. PubMed ID: 3111862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of human cytotoxic responses by complement: C3, C3b and C3d preparations enhance human allogeneic cytotoxic responses.
    Tsokos GC; Inghirami G; Lambris JD
    J Immunopharmacol; 1986; 8(4):529-41. PubMed ID: 2949021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
    Porteu F; Mir A; Halbwachs-Mecarelli L
    Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory effects of C3 and its major cleavage fragments.
    Fleisher TA; Berger M
    Clin Immunol Immunopathol; 1984 Dec; 33(3):391-401. PubMed ID: 6333950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation.
    Ghannam A; Fauquert JL; Thomas C; Kemper C; Drouet C
    Mol Immunol; 2014 Mar; 58(1):98-107. PubMed ID: 24321396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent binding of non-proteolysed C3 to Jurkat T cells.
    Barro CD; Villiers CL; Colomb MG
    Mol Immunol; 1991 Jul; 28(7):711-7. PubMed ID: 1830364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes.
    Edberg JC; Tosic L; Wright EL; Sutherland WM; Taylor RP
    J Immunol; 1988 Dec; 141(12):4258-65. PubMed ID: 3198918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.